Search Results - "Jimenez-Vicente, Carlos" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic

Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic

by Castaño-Díez, Sandra, Pomares, Helena, Esteban, Daniel, Guijarro, Francesca, Jiménez-Vicente, Carlos, Zugasti, Inés, Álamo, José Ramón, Mayayo, Víctor Torrecillas, López-Guerra, Mònica, de la Fuente, Cristina, Charry, Paola, Cortés-Bullich, Albert, Bataller, Álex, Maluquer, Clara, Colomer, Dolors, Rozman, María, Arnan, Montserrat, Xicoy, Blanca, Esteve, Jordi, Díaz-Beyá, Marina
Published in British journal of haematology (01.03.2024)

Get full text

Journal Article

Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group

Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group

by Jiménez‐Vicente, Carlos, Charry, Paola, Castaño‐Diez, Sandra, Guijarro, Francesca, López‐Guerra, Mònica, Pérez‐Valencia, Amanda Isabel, Martinez‐Roca, Alexandra, Cortés‐Bullich, Albert, Munárriz, Daniel, Solano, Maria Teresa, Rosiñol, Laura, Carreras, Enric, Urbano‐Ispizua, Álvaro, Fernández‐Avilés, Francesc, Martinez, Carmen, Suárez‐Lledó, María, Díaz‐Beyá, Marina, Rovira, Montserrat, Salas, María Queralt, Esteve, Jordi
Published in British journal of haematology (01.07.2024)

Get full text

Journal Article

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications

by Guijarro, Francesca, Castaño-Díez, Sandra, Jiménez-Vicente, Carlos, Garrote, Marta, Álamo, José Ramón, Gómez-Hernando, Marta, López-Oreja, Irene, Morata, Jordi, López-Guerra, Mònica, López, Cristina, Beà, Sílvia, Costa, Dolors, Colomer, Dolors, Díaz-Beyá, Marina, Rozman, Maria, Esteve, Jordi
Published in International journal of molecular sciences (08.08.2024)

Get full text

Journal Article

PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG‐TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS

PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG‐TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS

by Guardia‐Torrelles, Ares, Jimenez‐Vicente, Carlos, Roca, Alexandra Martínez, Castaño‐Díez, Sandra, Brillembourg, Helena, Guijarro, Francesca, Bataller, Àlex, Esteban, Daniel, Cortés, Albert, Zugasti, Inés, Munarriz, Daniel, Diaz‐Beya, Marina, Esteve, Jordi, Merchan, Beatriz
Published in HemaSphere (08.08.2023)

Get full text

Journal Article

P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMETHYLATING AGENTS

P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMETHYLATING AGENTS

by Jimenez‐Vicente, Carlos, Guijarro, Francesca, Lopez‐Guerra, Monica, Guardia‐Torrelles, Ares, Martínez Roca, Alexandra, Bataller, Alex, Esteban, Daniel, Cortés, Albert, Zugasti, Inés, Munarriz, Daniel, Colomer, Dolors, Diaz‐Beya, Marina, Esteve, Jordi
Published in HemaSphere (08.08.2023)

Get full text

Journal Article

Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients

Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients

by Baumann, Tycho, Moia, Riccardo, Gaidano, Gianluca, Delgado, Julio, Condoluci, Adalgisa, Villamor, Neus, Payedimarri, Anil Babu, Costa, Dolors, Patriarca, Andrea, Jiménez-Vicente, Carlos, Rossi, Davide, Montserrat, Emili
Published in Leukemia (01.08.2021)

Get full text

Journal Article

$Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia$

Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia

by Tolosa-Ridao, Carles, Suárez-Lledó, María, Jiménez-Vicente, Carlos, Cortés-Bullich, Albert, Merchan, Beatriz, Martínez-Roca, Alexandra, Guijarro, Francisca, Castaño-Díez, Sandra, Rosiñol, Laura, Fernández-Avilés, Francesc, Martínez, Carmen, Díaz-Beya, Marina, Esteve, Jordi, Rovira, Montserrat, Salas, María Queralt
Published in Bone marrow transplantation (Basingstoke) (01.08.2024)

Get full text

Journal Article

Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?

Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?

by Castaño-Díez, Sandra, Álamo, José Ramón, López-Guerra, Mònica, Gómez-Hernando, Marta, Zugasti, Inés, Jiménez-Vicente, Carlos, Guijarro, Francesca, López-Oreja, Irene, Esteban, Daniel, Charry, Paola, Torrecillas, Víctor, Mont-de Torres, Lucia, Cortés-Bullich, Albert, Bataller, Álex, Guardia, Ares, Munárriz, Daniel, Carcelero, Esther, Riu, Gisela, Triguero, Ana, Tovar, Natalia, Vela, Dolors, Beà, Silvia, Costa, Dolors, Colomer, Dolors, Rozman, Maria, Esteve, Jordi, Díaz-Beyá, Marina
Published in The oncologist (Dayton, Ohio) (30.09.2024)

Get full text

Journal Article

A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition

A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition

by Jiménez-Vicente, Carlos, Garrote, Marta, López-Guerra, Mónica, Villamón, Eva, Guijarro, Francesca, Perez-Valencia, Amanda Isabel, Martinez-Roca, Alexandra, Balaguer, Olga, Álvarez-Larrán, Alberto, Hernández-Boluda, Juan Carlos, Rovira, Montserrat, Colomer, Dolors, Diaz-Beyá, Marina, Rozman, Maria, Esteve, Jordi
Published in Leukemia & lymphoma (01.03.2024)

Get more information

Journal Article

Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study

Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study

by Jiménez-Vicente, Carlos, Guardia-Torrelles, Ares, Pérez-Valencia, Amanda Isabel, Martínez-Roca, Alexandra, Castaño-Diez, Sandra, Guijarro, Francesca, Cortés-Bullich, Albert, Merchán, Beatriz, Triguero, Ana, Hernández, Isabel, Brillembourg, Helena, Munárriz, Daniel, Zugasti, Inés, Fernández-Avilés, Francesc, Diaz-Beyá, Marina, Esteve, Jordi
Published in Annals of hematology (01.10.2024)

Get full text

Journal Article

Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF

Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF

by Jiménez-Vicente, Carlos, Martínez-Roca, Alexandra, Pomares, Helena, Castaño-Diez, Sandra, Guijarro, Francesca, López-Guerra, Mònica, Bataller, Alex, Esteban, Daniel, Cortés-Bullich, Albert, Pérez-Valencia, Amanda Isabel, Guardia-Torrelles, Ares, Zugasti, Inés, Rovira, Montserrat, Fernández-Avilés, Francesc, Colomer, Dolors, Arnan, Montserrat, Díaz-Beyá, Marina, Esteve, Jordi
Published in Leukemia research (01.12.2023)

Get full text

Journal Article

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

by Castaño-Díez, Sandra, López-Guerra, Mónica, Bosch-Castañeda, Cristina, Bataller, Alex, Charry, Paola, Esteban, Daniel, Guijarro, Francesca, Jiménez-Vicente, Carlos, Castillo-Girón, Carlos, Cortes, Albert, Martínez-Roca, Alexandra, Triguero, Ana, Álamo, José Ramón, Beà, Silvia, Costa, Dolors, Colomer, Dolors, Rozman, María, Esteve, Jordi, Díaz-Beyá, Marina
Published in Cancers (25.08.2022)

Get full text

Journal Article

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome

by Guijarro, Francesca, López-Guerra, Monica, Morata, Jordi, Bataller, Alex, Paz, Sara, Cornet-Masana, Josep Maria, Banús-Mulet, Antònia, Cuesta-Casanovas, Laia, Carbó, Josep Maria, Castaño-Díez, Sandra, Jiménez-Vicente, Carlos, Cortés-Bullich, Albert, Triguero, Ana, Martínez-Roca, Alexandra, Esteban, Daniel, Gómez-Hernando, Marta, Álamo Moreno, José Ramón, López-Oreja, Irene, Garrote, Marta, Risueño, Ruth M., Tonda, Raúl, Gut, Ivo, Colomer, Dolors, Díaz-Beya, Marina, Esteve, Jordi
Published in Blood advances (10.10.2023)

Get full text

Journal Article

Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy

Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy

by Sobrino Jiménez, Carmen, Romero-Garrido, José Antonio, García-Martín, Ángeles, Quintana-Díaz, Manuel, Jiménez-Vicente, Carlos, González-Del Valle, Luis, Herrero Ambrosio, Alicia, Benedí-González, Juana
Published in European journal of hospital pharmacy. Science and practice (01.11.2021)

Get full text

Journal Article

Clinical Characterization of Fusion Genes in Acute Myeloid Leukemia without Recurrent Genetic Abnormalities

Clinical Characterization of Fusion Genes in Acute Myeloid Leukemia without Recurrent Genetic Abnormalities

by Guijarro, Francesca, Dabad, Marc, López-Guerra, Mònica, Bataller Torralba, Alex, Castaño-Díez, Sandra, Jimenez-Vicente, Carlos, Garrote, Marta, Álamo Moreno, José Ramón, Pratcorona, Marta, Villamor, Neus, Colomer, Dolors, Bea, Silvia, Costa, Dolors, Esteve-Codina, Anna, Díaz-Beyá, Marina, Esteve, Jordi
Published in Blood (02.11.2023)

Get full text

Journal Article

Validation of ELN 2022 Risk Classification in Patients Diagnosed with AML Undergoing Allogeneic Hematopoietic Cell Transplantation

Validation of ELN 2022 Risk Classification in Patients Diagnosed with AML Undergoing Allogeneic Hematopoietic Cell Transplantation

by Jimenez-Vicente, Carlos, Charry, Paola, Suarez-Lledo, Maria, Merchán Muñoz, Beatriz, Castaño-Díez, Sandra, Perez-Valencia, Amanda Isabel, Martínez-Roca, Alexandra, Guijarro, Francesca, López-Guerra, Mònica, Cortés-Bullich, Albert, Esteban, Daniel, Guardia-Torrelles, Ares, Zugasti, Ines, Munárriz, Daniel, Rosiñol, Laura, Urbano-Ispizua, Alvaro, Fernández-Avilés, Francesc, Martinez, Carmen, Díaz-Beyá, Marina, Rovira, Montserrat, Salas, Maria Queralt, Esteve, Jordi
Published in Blood (02.11.2023)

Get full text

Journal Article

$Allogeneic Hematopoietic Cell Transplantation with Sequential-Based Conditioning in Refractory / Relapsed Acute Myeloid Leukemia: Experience from a Single Institution$

Allogeneic Hematopoietic Cell Transplantation with Sequential-Based Conditioning in Refractory / Relapsed Acute Myeloid Leukemia: Experience from a Single Institution

by Tolosa-Ridao, Carles, Charry, Paola, Suarez-Lledo, Maria, Esteban, Daniel, Díaz-Beyá, Marina, Cortés-Bullich, Albert, Merchán Muñoz, Beatriz, Martínez-Roca, Alexandra, Solano, Maria Teresa, Guijarro, Francesca, Castaño-Díez, Sandra, Jimenez-Vicente, Carlos, Nomdedeu, Meritxell, Cid, Joan, Lozano, Miquel, Pedraza, Alexandra, Rosiñol, Laura, Carreras, Enric, Urbano-Ispizua, Alvaro, Fernández-Avilés, Francesc, Martinez, Carmen, Esteve, Jordi, Rovira, Montserrat, Salas, Maria Queralt
Published in Blood (02.11.2023)

Get full text

Journal Article

Evaluation of the Use of Post-Transplant Cyclophosphamide in Patients Diagnosed of Myelodysplastic Syndrome Who Undergo Allogenic Hematopoietic Cell Transplantation

Evaluation of the Use of Post-Transplant Cyclophosphamide in Patients Diagnosed of Myelodysplastic Syndrome Who Undergo Allogenic Hematopoietic Cell Transplantation

by Tolosa-Ridao, Carles, Charry, Paola, Castaño-Díez, Sandra, Suarez-Lledo, Maria, Merchán Muñoz, Beatriz, Esteban, Daniel, Cortés-Bullich, Albert, Guijarro, Francesca, Solano, Maria Teresa, Martínez-Roca, Alexandra, Jimenez-Vicente, Carlos, Rosiñol, Laura, Carreras, Enric, Urbano-Ispizua, Alvaro, Fernández-Avilés, Francesc, Martinez, Carmen, Esteve, Jordi, Rovira, Montserrat, Díaz-Beyá, Marina, Salas, Maria Queralt
Published in Blood (02.11.2023)

Get full text

Journal Article

Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA ) Identify a High-Risk CMML Group Independent of Molecular-Cpss

Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA ) Identify a High-Risk CMML Group Independent of Molecular-Cpss

by Castaño-Díez, Sandra, Zugasti, Ines, Calvo, Xavier, Schulz, Felicitas, Avendaño Pita, Alejandro, Mora, Elvira, Falantes, Jose Francisco, Azaceta, Gemma, Ibáñez, Mariam, Chen, Tzu, Notario, Cristina, Amer Salas, Neus, López-Guerra, Mònica, Jimenez-Vicente, Carlos, Esteban, Daniel, Guijarro, Francesca, Álamo Moreno, José Ramón, Cortés-Bullich, Albert, Munárriz, Daniel, Torrecillas-Mayayo, Víctor, Triguero, Ana, Tovar, Natalia, Martínez-Roca, Alexandra, Merchán Muñoz, Beatriz, Carcelero, Esther, Germing, Ulrich, Betz, Beate, Rozman, María, Arenillas, Leonor, Zamora, Lurdes, Diez-Campelo, Maria, Xicoy, Blanca, Esteve, Jordi, Díaz-Beyá, Marina
Published in Blood (02.11.2023)

Get full text

Journal Article

Venetoclax and Azacytidine Treatment for High Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia As a Bridge Therapy to Transplant. a GESMD Study

Venetoclax and Azacytidine Treatment for High Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia As a Bridge Therapy to Transplant. a GESMD Study

by Zugasti, Ines, Castaño-Díez, Sandra, Esteban, Daniel, Avendaño Pita, Alejandro, Pomares, Helena, Pérez González, Ana, Garcia-Avila, Sara, Padilla-Conejo, Irene, de la Fuente, Cristina, Martínez-Roca, Alexandra, Guijarro, Francesca, Álamo Moreno, José Ramón, Jimenez-Vicente, Carlos, Cortés-Bullich, Albert, Torrecillas, Victor, Guardia, Ares, Munárriz, Daniel, Carcelero, Esther, Suarez-Lledo, Maria, Salas, Maria Queralt, Lopez, Felix, Ramos, Fernando, Xicoy, Blanca, Valcarcel, David, Arnan Sangerman, Montserrat, Diez-Campelo, Maria, Martinez, Carmen, Rovira, Montserrat, Fernández-Avilés, Francesc, Esteve, Jordi, Díaz-Beyá, Marina
Published in Blood (02.11.2023)

Get full text

Journal Article